Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Monday, July 15, 2024 | Back issues
Courthouse News Service Courthouse News Service

Investing in Big Pharma

Shares dropped more than 50 percent to $6.39 after Amicus Therapeutics corrected a press release that had misrepresented the progress of its new Fabry disease treatment, migalastat, a class of investors claims.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.